Clínic Barcelona

The kick-off meeting of the IDIBAPS Translational Cancer Research Programme has been held

The aim of the new programme is to increase the survival of cancer patients by improving the detection of populations at risk and early diagnosis, as well as defining predictors of response and resistance to molecular therapies.  The approach adopted in the proposed project includes the application of innovative biomedical technologies, such as artificial intelligence, single-cell sequencing, spatial transcriptomics, patient-derived organoids, and genetically engineered mouse models.    

Related contents
Keep reading about: